Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals

Science

TOKYO (Reuters) – Japanese biopharmaceutical firm Anges Inc said on Tuesday it and partner Osaka University had completed development of a prophylactic DNA vaccine against the new coronavirus and that it would begin testing it in animals soon.

Shares of Anges were untraded with a glut of buy orders in early morning.

There are now more than 350,000 cases of coronavirus infections globally and over 15,000 deaths resulting from the disease it causes, called COVID-19.

Reporting by Chang-Ran Kim; Editing by Kim Coghill

Products You May Like

Articles You May Like

Prepare to study in Canada
Study permit: Who can apply
British Columbia Conducts First PNP Draws Since Overhaul Of Provincial Immigration Program
Boost PNP Slots For International Students, Conference Board Says
Toronto, British Columbia and McGill Named Among Top 100 Best Universities In World
Newfoundland And Labrador Wants Its Provincial Canada Immigration Allotment Doubled
Nurse Aides And Orderlies Can Now Immigrate To Canada Through Express Entry 

Leave a Reply

Your email address will not be published. Required fields are marked *